Therapeutic Effect of Berberine on Insomnia Rats by ErbB Signaling Pathway

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2020 Jul 6

PMID 32623439

Citations 2

Authors

Qingquan Wang

Xiaojuan Ren

Xingping Zhang

Guanying Wang

Hongxia Xu

Ning Deng

Tao Liu

Zhipeng Peng

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Insomnia seriously affects people's health and quality of life. Short-term use of Western drugs may also be harmful. Traditional Chinese medicine has been widely used to treat diseases in world. Therefore, this paper aims to study the therapeutic effect of berberine based on the insomnious rat model. MATERIAL AND METHODS The insomnia rat model was established by intragastric administration of caffeine and parachlorophenylalanine (PCPA). Berberine and diazepam were used to treat the established insomnia rats. Then, the pathological changes of insomnia rats were detected. In addition, transcriptome sequencing and data analysis were carried out using rat hippocampus. The expression of key genes was verified by quantitative polymerase chain reaction and western blot. RESULTS After 7 days of intragastric administration of berberine, the body weight, memory, and sleep quality of insomnia rats were significantly improved. The key roles of Erbb4, Erbb2, Ar, and Grin2a in berberine treatment were identified. Through the analysis of biological functions and signaling pathways, berberine was shown to play a salutary role through nervous system development and ErbB signaling pathway. Gene-set enrichment analysis (GSEA) results showed that berberine treatment affected more metabolic pathways. Compared with diazepam, berberine can play a faster role, and also improve the overall health level of insomnia rats. CONCLUSIONS These results suggest that berberine can alleviate insomnia in rats through a neuroprotective effect and improved metabolic level. Berberine has great potential in treatment of insomnia and might have better clinical significance.

Citing Articles

Proteomics Reveals Molecular Changes in Insomnia Patients with More Dreams.

Liu T, Zhang X, Wang G, Liu X, Liang Z, Ren X Comput Math Methods Med. 2022; 2022:6181943.

PMID: 35432581 PMC: 9012652. DOI: 10.1155/2022/6181943.

Discovery of the Potential Novel Pharmacodynamic Substances From Zhi-Zi-Hou-Po Decoction Based on the Concept of Co-Decoction Reaction and Analysis Strategy.

Feng X, Bi Y, Wang J, Li T, Yu G, Zhang T Front Pharmacol. 2022; 12:830558.

PMID: 35095537 PMC: 8793358. DOI: 10.3389/fphar.2021.830558.

References

Pitcher G, Kalia L, Ng D, Goodfellow N, Yee K, Lambe E . Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med. 2011; 17(4):470-8. PMC: 3264662. DOI: 10.1038/nm.2315. View

Bjorvatn B, Meland E, Flo E, Mildestvedt T . High prevalence of insomnia and hypnotic use in patients visiting their general practitioner. Fam Pract. 2016; 34(1):20-24. DOI: 10.1093/fampra/cmw107. View

Irwin M, Olmstead R, Carroll J . Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2015; 80(1):40-52. PMC: 4666828. DOI: 10.1016/j.biopsych.2015.05.014. View

Meier-Ewert H, Ridker P, Rifai N, Regan M, Price N, Dinges D . Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004; 43(4):678-83. DOI: 10.1016/j.jacc.2003.07.050. View

Hanlon E, Van Cauter E . Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism. Proc Natl Acad Sci U S A. 2011; 108 Suppl 3:15609-16. PMC: 3176603. DOI: 10.1073/pnas.1101338108. View

Kulkarni S, Dhir A . On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol. 2008; 589(1-3):163-72. DOI: 10.1016/j.ejphar.2008.05.043. View

Ahrens S, Jaramillo S, Yu K, Ghosh S, Hwang G, Paik R . ErbB4 regulation of a thalamic reticular nucleus circuit for sensory selection. Nat Neurosci. 2014; 18(1):104-11. PMC: 4281280. DOI: 10.1038/nn.3897. View

Winkelman J, Plante D, Schoerning L, Benson K, Buxton O, OConnor S . Increased Rostral Anterior Cingulate Cortex Volume in Chronic Primary Insomnia. Sleep. 2013; 36(7):991-998. PMC: 3669070. DOI: 10.5665/sleep.2794. View

Allebrandt K, Teder-Laving M, Cusumano P, Frishman G, Levandovski R, Ruepp A . Identifying pathways modulating sleep duration: from genomics to transcriptomics. Sci Rep. 2017; 7(1):4555. PMC: 5496883. DOI: 10.1038/s41598-017-04027-7. View

10.

Fernandez-Mendoza J, Baker J, Vgontzas A, Gaines J, Liao D, Bixler E . Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Brain Behav Immun. 2017; 61:110-116. PMC: 5316336. DOI: 10.1016/j.bbi.2016.12.026. View

11.

Dashti H, Jones S, Wood A, Lane J, van Hees V, Wang H . Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019; 10(1):1100. PMC: 6405943. DOI: 10.1038/s41467-019-08917-4. View

12.

Zhu J, Li K, Cao S, Chen X, Shen C, Zhang Y . Increased NRG1-ErbB4 signaling in human symptomatic epilepsy. Sci Rep. 2017; 7(1):141. PMC: 5428003. DOI: 10.1038/s41598-017-00207-7. View

13.

Parthasarathy S, Vasquez M, Halonen M, Bootzin R, Quan S, Martinez F . Persistent insomnia is associated with mortality risk. Am J Med. 2014; 128(3):268-75.e2. PMC: 4340773. DOI: 10.1016/j.amjmed.2014.10.015. View

14.

Ni X, Shergis J, Zhang A, Guo X, Lu C, Li Y . Traditional Use of Chinese Herbal Medicine for Insomnia and Priorities Setting of Future Clinical Research. J Altern Complement Med. 2018; 25(1):8-15. DOI: 10.1089/acm.2018.0249. View

15.

Li Y, Zhang X, Winkelman J, Redline S, Hu F, Stampfer M . Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2013; 129(7):737-46. PMC: 3987964. DOI: 10.1161/CIRCULATIONAHA.113.004500. View

16.

Suh S, Kim H, Dang-Vu T, Joo E, Shin C . Cortical Thinning and Altered Cortico-Cortical Structural Covariance of the Default Mode Network in Patients with Persistent Insomnia Symptoms. Sleep. 2015; 39(1):161-71. PMC: 4678334. DOI: 10.5665/sleep.5340. View

17.

Joshi M, Krishnakumar A . Hypoglycemia causes dysregulation of Neuregulin 1, ErbB receptors, Ki67 in cerebellum and brainstem during diabetes: Implications in motor function. Behav Brain Res. 2019; 372:112029. DOI: 10.1016/j.bbr.2019.112029. View

18.

Strehlow V, Heyne H, Vlaskamp D, Marwick K, Rudolf G, de Bellescize J . GRIN2A-related disorders: genotype and functional consequence predict phenotype. Brain. 2018; 142(1):80-92. PMC: 6308310. DOI: 10.1093/brain/awy304. View

19.

Budkowska M, Ostrycharz E, Wojtowicz A, Marcinowska Z, Wozniak J, Ratajczak M . A Circadian Rhythm in both Complement Cascade (ComC) Activation and Sphingosine-1-Phosphate (S1P) Levels in Human Peripheral Blood Supports a Role for the ComC-S1P Axis in Circadian Changes in the Number of Stem Cells Circulating in Peripheral Blood. Stem Cell Rev Rep. 2018; 14(5):677-685. PMC: 6132735. DOI: 10.1007/s12015-018-9836-7. View

20.

Fernandez-Mendoza J, Vgontzas A, Liao D, Shaffer M, Vela-Bueno A, Basta M . Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012; 60(4):929-35. PMC: 3679545. DOI: 10.1161/HYPERTENSIONAHA.112.193268. View